Overview
Jeroen Hiltermann practices practicing medicine in Groningen, Netherlands.
Hiltermann is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), ALK-Positive Non-Small Cell Lung Cancer, EGFR Positive Lung Cancer, and Tissue Biopsy.
They are actively involved in clinical research, co-authoring 77 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jeroen N. Hiltermann
Is Jeroen N. Hiltermann a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Jeroen N. Hiltermann is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jeroen N. Hiltermann participate in research or clinical trials?
Yes. Jeroen N. Hiltermann has published 77 articles and abstracts on conditions like Lung Cancer. You can view a list of Jeroen N. Hiltermann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerHiltermann isDistinguished. Learn about Lung Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- EGFR Positive Lung CancerHiltermann isExperienced. Learn about EGFR Positive Lung Cancer.
- Familial Prostate CancerHiltermann isExperienced. Learn about Familial Prostate Cancer.
- Giant Cell Arteritis (GCA)Hiltermann isExperienced. Learn about Giant Cell Arteritis (GCA).
- Juvenile Temporal ArteritisHiltermann isExperienced. Learn about Juvenile Temporal Arteritis.
- Lung AdenocarcinomaHiltermann isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesHiltermann isExperienced. Learn about Lung Metastases.
- Muscle AtrophyHiltermann isExperienced. Learn about Muscle Atrophy.
- PIK3CA-Related Overgrowth SpectrumHiltermann isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Polymyalgia RheumaticaHiltermann isExperienced. Learn about Polymyalgia Rheumatica.
- Rhizomelic PseudopolyarthritisHiltermann isExperienced. Learn about Rhizomelic Pseudopolyarthritis.
- Small Cell Lung Cancer (SCLC)Hiltermann isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Temporal ArteritisHiltermann isExperienced. Learn about Temporal Arteritis.
- Tissue BiopsyHiltermann isExperienced. Learn about Tissue Biopsy.
- VasculitisHiltermann isExperienced. Learn about Vasculitis.